PASITHEA THERAPEUTICS CORP. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PASITHEA THERAPEUTICS CORP. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $8.48K.
- PASITHEA THERAPEUTICS CORP. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $750.00, a 13.89% decline year-over-year.
- PASITHEA THERAPEUTICS CORP. stock issued during period, value, stock options exercised for the quarter ending 2025-03-31 was $871.00.
- PASITHEA THERAPEUTICS CORP. stock issued during period, value, stock options exercised for the quarter ending 2024-09-30 was $4.52M.
- PASITHEA THERAPEUTICS CORP. stock issued during period, value, stock options exercised for fiscal 2025 was $871.00, a 149.57% increase from fiscal 2024.
- PASITHEA THERAPEUTICS CORP. stock issued during period, value, stock options exercised for fiscal 2024 was $349.00, a 99.93% decline from fiscal 2023.
- PASITHEA THERAPEUTICS CORP. stock issued during period, value, stock options exercised for fiscal 2023 was $520.53K, a 18.31% increase from fiscal 2022.
- PASITHEA THERAPEUTICS CORP. stock issued during period, value, stock options exercised for fiscal 2022 was $439.98K, a 93.71% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $8.48K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $750.00 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $871.00 10-K · filed 2026-03-30 | |
| 2025-03-31 | $871.00 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $349.00 10-K · filed 2026-03-30 | |
| 2024-09-30 | $4.52M 10-Q · filed 2024-11-13 | |
| 2023-12-31 | $520.53K 10-K · filed 2024-03-29 | |
| 2023-06-30 | $194.72K 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $153.37K 10-Q · filed 2023-08-11 | |
| 2022-12-31 | $439.98K 10-K · filed 2024-03-29 | |
| 2022-06-30 | $99.54K 10-Q · filed 2023-08-11 | |
| 2022-03-31 | $94.30K 10-Q · filed 2023-08-11 | |
| 2021-12-31 | $7.00M 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |